Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

GTA182 demonstrates favorable safety, dose-proportional pharmacokinetics, robust PRMT5 pathway inhibition, and encouraging ...

As we scroll through feeds that feel more like mirrors than marketplaces, are we hunting for deals, or are the deals are ...

The answer, according to new research from the data and AI platform company, is sobering. Even the best-performing AI agents achieve less than 45% accuracy on tasks that mirror real enterprise ...

Human spaceflight is built on a simple paradox: the farther people travel from Earth, the more fragile their bodies and ...

As of the November 30, 2025 data cutoff, two patients with non-Hodgkin's lymphoma had completed multiple GT801 administrations without lymphodepleting chemotherapy, demonstrating the feasibility of ...

For patients whose time to progression on immediate prior therapy was >18 months, median progression-free survival (“PFS”) was 12.4 months ...

Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors view more . Credit: Insilico ...

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden ...

This study conducts a performance evaluation of a blockchain-based Human Resource Management System (HRMS) utilizing smart ...

How SA leaders are reshaping enterprise CX in the age of AIIssued by ConnectJohannesburg, 10 Dec 2025 Greg Jarvis, Head of Customer Success at Connect SA. South Africa’s customer experience (CX) ...